5-19483313-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004934.5(CDH18):c.1870C>A(p.Leu624Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,612,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004934.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH18 | NM_004934.5 | c.1870C>A | p.Leu624Ile | missense_variant | 12/13 | ENST00000382275.6 | NP_004925.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH18 | ENST00000382275.6 | c.1870C>A | p.Leu624Ile | missense_variant | 12/13 | 1 | NM_004934.5 | ENSP00000371710 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000719 AC: 18AN: 250198Hom.: 0 AF XY: 0.0000592 AC XY: 8AN XY: 135192
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1460910Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726716
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74278
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 26, 2024 | The c.1870C>A (p.L624I) alteration is located in exon 12 (coding exon 10) of the CDH18 gene. This alteration results from a C to A substitution at nucleotide position 1870, causing the leucine (L) at amino acid position 624 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at